Articles by James Calloway
Circle shares slide as USDC supply drop raises earnings stakes
Circle shares dropped 5.3% premarket as USDC supply fell to $71.8B, raising pressure on upcoming Q2 earnings. Morgan Stanley downgraded the stock.
Microsoft's $678B Backlog Fuels Stock Rally, Azure Growth Outpaces Forecasts
Microsoft's commercial backlog hit $678B, Azure grew 43%, and the stock surged to record highs. The company's strong guidance and expanding AI footprint beyond OpenAI are driving investor enthusiasm.
Roblox shares near low as safety costs outpace user spending
Roblox shares hover near their 52-week low as increased safety spending outpaces user monetization, with Q3 bookings guidance missing estimates.
Amazon Stock Nears Record High as AWS Backlog Surges to $496B
Amazon shares edged toward their 52-week peak as AWS backlog surged to $496 billion, underpinning a $220 billion AI investment plan.
Palantir Q2 Report Looms as Commercial Revenue Nears Government Sales
Palantir's Q2 earnings arrive Monday as US commercial revenue nears government sales, with a potential crossover signaling AI-driven growth. Analysts expect modest revenue beat.
FDA Panel Nod Sparks $763M Value Shift Between Melanoma Drugmakers
Replimune (REPL) soared 107% after an FDA panel endorsed RP1, while Iovance (IOVA) tumbled 13%, shifting $763 million in market value between the two melanoma therapy rivals.
BP's North Sea Exit Could Cover 13% of $20B Divestment Goal
BP's planned North Sea divestment, valued at $2B-$2.6B, could cover up to 13% of its $20B asset sale target, ahead of Q2 earnings where net debt is forecast at $22-$23B.




